Abstract:Back in the year 2009, we presented in this journal a neonate with an unusual combination of congenital lactic acidosis and bilateral calcifications in the adrenal medulla 1 . After prenatal ultrasound examination at 21 weeks had revealed intrauterine growth retardation and pericardial effusions, labor was induced at 38 weeks of pregnancy. The patient was hypotonic at birth, had respiratory insufficiency necessitating intubation and artificial ventilation, hepatomegaly and severe cardiomegaly. Intensive care was withdrawn in accordance with parents' wishes on day 38. At the time, the patient's causal genetic defect had remained unknown, yet clinical and biochemical evidence ticked all the boxes of an underlying mitochondrial defect. Postmortem spectrophotometric evaluation then revealed decreased oxidative phosphorylation activities in heart muscle (complex IV) and liver (complexes I, III, IV and V), and normal activities in skeletal muscle and cultured skin fibroblasts. Blue-native polyacrylamide gel electrophoresis of liver extracts confirmed decreased activities of complexes III and IV and showed the presence of subcomplexes of complex V. Thanks to the great genetic leap forward taken by medical research ever since, we were now able to thoroughly investigate the patient's whole exome extracted from preserved cultured skin fibroblasts. These investigations picked up compound heterozygous missense variants in the gene encoding the mitochondrial leucyl-tRNA synthetase ( LARS2 ): c.302 A > G (p.His101Arg) and c.516 G > T (p.Arg172Ser). Nuclear-encoded mitochondrion-specific aminoacyl-tRNA synthetases exist for 17 of the 20 proteogenic amino acids, and pathogenic mutations have now been reported for each one of these 2 . At the time we published our casus, LARS2 defects had not been reported, yet between the year 2013 and now, a total of 23 patients have been described that carry disease-causing LARS2 variants (Table 1) 1,3,4,5,6,7,8,9,10,11,12,13 . Their diverse associated disease phenotypes, which include Perrault syndrome, multisystem disease, leukodystrophy and intellectual disability, do not appear to have an obvious link with genotype. With the casus we presented in this journal and now have characterized at the molecular level, more than twenty patients with 18 unique combinations of disease-causing LARS2 variants have been reported so far, only one was homozygous the others concerned compound heterozygous variants. Table 1 Published patients carrying disease-causing LARS2 variants. Full size table

Biallelic mutations in LARS2 can cause Perrault syndrome type 2 with neurologic symptoms

LARS2-Perrault syndrome: a new case report and literature review

LARS2 variants can present as premature ovarian insufficiency in the absence of overt hearing loss

First independent replication of the involvement of LARS2 in Perrault syndrome by whole-exome sequencing of an Italian family

Delayed Diagnosis of Perrault Syndrome: A Rare Genetic Disorder

Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian dysgenesis and sensorineural hearing loss of Perrault syndrome

New insights into Perrault syndrome, a clinically and genetically heterogeneous disorder

Axonal polyneuropathy and ataxia in children: consider Perrault Syndrome, a case report

Mutations of Human NARS2, Encoding the Mitochondrial Asparaginyl-Trna Synthetase, Cause Nonsyndromic Deafness and Leigh Syndrome

A Homozygous Missense Variant in HSD17B4 Identified in a Consanguineous Chinese Han Family with Type II Perrault Syndrome

Genomic sequencing highlights the diverse molecular causes of Perrault syndrome: a peroxisomal disorder (PEX6), metabolic disorders (CLPP, GGPS1), and mtDNA maintenance/translation disorders (LARS2, TFAM)

Exome sequencing reveals pathogenic mutations in the LARS2 and HSD17B4 genes associated with Perrault syndrome and D-bifunctional protein deficiency in Moroccan families

Neonatal lactic acidosis explained by LARS2 defect

Homozygous novel truncating variant of CLPP associated with severe Perrault syndrome

Detailed characterization of auditory neuropathy in Perrault syndrome with TWNK variants

The Genotypic and Phenotypic Spectrum of PARS2-related Infantile-Onset Encephalopathy.

A Novel Missense Mutation in TWNK Gene Causing Perrault Syndrome Type 5 in a Chinese Family and Review of the Literature

Compound heterozygous mutation of the IARS2 gene: a rare cause of Leigh Syndrome

Mutations in KARS cause a severe neurological and neurosensory disease with optic neuropathy

Clinical and genetic analysis of a patient with Perrault syndrome and additional neurological features

A novel mutation of Twinkle in Perrault syndrome: A not rare diagnosis?